1.34
Precedente Chiudi:
$1.45
Aprire:
$1.37
Volume 24 ore:
25,082
Relative Volume:
0.02
Capitalizzazione di mercato:
$54.05M
Reddito:
$13.42M
Utile/perdita netta:
$-73.35M
Rapporto P/E:
-0.6979
EPS:
-1.92
Flusso di cassa netto:
$-56.34M
1 W Prestazione:
-4.29%
1M Prestazione:
+36.04%
6M Prestazione:
+30.10%
1 anno Prestazione:
-2.89%
Barinthus Biotherapeutics Plc Adr Stock (BRNS) Company Profile
Nome
Barinthus Biotherapeutics Plc Adr
Settore
Industria
Telefono
44 (0) 1865 818808
Indirizzo
20400 CENTURY BLVD, GERMANTOWN
Confronta BRNS con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
BRNS
Barinthus Biotherapeutics Plc Adr
|
1.34 | 52.84M | 13.42M | -73.35M | -56.34M | -1.92 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
![]()
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
Barinthus Biotherapeutics Plc Adr Stock (BRNS) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2021-05-25 | Iniziato | Jefferies | Buy |
2021-05-25 | Iniziato | Morgan Stanley | Overweight |
2021-05-25 | Iniziato | William Blair | Outperform |
2021-05-24 | Iniziato | H.C. Wainwright | Buy |
Barinthus Biotherapeutics Plc Adr Borsa (BRNS) Ultime notizie
BRNS’s Market Whiplash: 50.99% YTD Rise, 152.41% Rise in 30 Days - investchronicle.com
BRNS stock touches 52-week low at $0.8 amid market volatility - Investing.com UK
Barinthus Biotherapeutics PLC Sponsored ADR (BRNS) Upgraded to Strong Buy: Here's Why - MSN
Barinthus Bio shifts focus, cuts workforce to extend cash runway - Investing.com
The big rebrand: Why these 4 biopharmas changed their name this year - PharmaVoice
Barinthus Bio intiates Phase 1 clinical trial of VTP-1000 for treatment of coeliac disease - European Pharmaceutical Manufacturer
Mexico Shingles Vaccine Market Size & Outlook, 2023-2030 - Grand View Research
Tango Therapeutics, Inc. (TNGX) Reports Q4 Loss, Lags Revenue Estimates - Yahoo Finance
Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time - MarketBeat
Barinthus Biotherapeutics Plc Adr Azioni (BRNS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):